Synthesis and characterisation of (Z)-styrylbenzene derivatives as potential selective anticancer agents

References

• Mahapatra DK, Bharti SK, Asati V. Anti-cancer chalcones: structural and molecular target perspectives. Eur J Med Chem 2015;98:69–114.
   PubMed Web of Science ®Google Scholar
• Ma J, Li JJ, Tian YS. Synthesis and bioactivity evaluation of 2,3-diaryl acrylonitrile derivatives as potential anticancer agents. Bioorg Med Chem Lett 2017;27:81–5.
   PubMed Web of Science ®Google Scholar
• Huang XC, Jin L, Wang M. Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents. Eur J Med Chem 2015;89:370–85.
   PubMed Web of Science ®Google Scholar
• Al-Obaid AM, Abdel-Hamide SG, El-Kashef HA, et al. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs. Eur J Med Chem 2009;44:2379–91.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Newman DJ. Nature: a vital source of leads for anticancer drug development. Phytochem Rev 2009;8:313–31.
   Web of Science ®Google Scholar
• Zheng SL, Zhong Q, Mottamal M, et al. Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents. J Med Chem 2014;57:3369–81.
   PubMed Web of Science ®Google Scholar
• Madadi NR, Penthala NR, Howk K, et al. Synthesis and biological evaluation of novel 4,5-disubstituted 2H-1,2,3-triazoles as cis-constrained analogues of combretastatin A-4. Eur J Med Chem 2015;103:123–32.
   PubMed Web of Science ®Google Scholar
• Qi J, Dong H, Huang J, et al. Synthesis and biological evaluation of N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid derivatives as tubulin polymerization inhibitors. Eur J Med Chem 2018;143:8–20.
   PubMed Web of Science ®Google Scholar
• Ohsumi K, Nakagawa R, Fukuda Y, et al. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships. J Med Chem 1998;41:3022–32.
   PubMed Web of Science ®Google Scholar
• Demchuk DV, Samet AV, Chernysheva NB, et al. Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines. Bioorg Med Chem 2014;22:738–55.
   PubMed Web of Science ®Google Scholar
• Banimustafa M, Kheirollahi A, Safavi M, et al. Synthesis and biological evaluation of 3-(trimethoxyphenyl)-2(3H)-thiazole thiones as combretastatin analogs. Eur J Med Chem 2013;70:692–702.
   PubMed Web of Science ®Google Scholar
• Madadi NR, Penthala NR, Song L, et al. Preparation of 4,5 disubstituted-2H-1,2,3-triazoles from (Z)-2,3-diaryl substituted acrylonitriles. Tetrahedron Lett 2014;55:4207–11.
   Web of Science ®Google Scholar
• Carr M, Greene LM, Knox AJS, et al. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects. Eur J Med Chem 2010;45:5752–66.
   PubMed Web of Science ®Google Scholar
• Samanta S, Lim TL, Lam YL. Synthesis and in vitro evaluation of West Nile Virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4] triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold. ChemMedChem 2013;8:994–1001.
   PubMed Web of Science ®Google Scholar
• Li YT, Wang JH, Pan CW, et al. Syntheses and biological evaluation of 1,2,3-triazole and 1,3,4-oxadiazole derivatives of imatinib. Bioorg Med Chem Lett 2016;26:1419–27.
   PubMed Web of Science ®Google Scholar
• Srivastava V, Darokar MP, Fatima A, et al. Synthesis of diverse analogues of oenostacin and their antibacterial activities. Bioorg Med Chem 2007;15:518–25.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Das UK, Ben-David Y, et al. Manganese catalyzed α-olefination of nitriles by primary alcohols. J Am Chem Soc 2017;139:11710–3.
   PubMed Web of Science ®Google Scholar
• Petch D, Anderson RJ, Cunningham A, et al. Design and synthesis of EGFR dimerization inhibitors and evaluation of their potential in the treatment of psoriasis. Bioorg Med Chem 2012;20:5901–14.
   PubMed Web of Science ®Google Scholar
• Lieber S, Scheer F, Meissner W, et al. (Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}-acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties. J Med Chem 2012;55:2858–68.
   PubMed Web of Science ®Google Scholar
• Tanpure RP, Strecker TE, Chaplin DJ, et al. Regio- and stereospecific synthesis of mono-beta-d-glucuronic acid derivatives of combretastatin A-1. J Nat Prod 2010;73:1093–101.
   PubMed Web of Science ®Google Scholar
• Liu CF, Shen QK, Li JJ, et al. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents. J Enzyme Inhib Med Chem 2017;32:1111–9.
   PubMed Web of Science ®Google Scholar
• Tian YS, Kim HJ, Kim HM. Rho-associated kinase (ROCK) inhibition reverses low cell activity on hydrophobic surfaces. Biochem Biophys Res Commun 2009;386:499–503.
   PubMed Web of Science ®Google Scholar
• Zhang HJ, Zhang GR, Piao HR, et al. Synthesis and characterisation of celastrol derivatives as potential anticancer agents. J Enzyme Inhib Med Chem 2017;33:190–8.
   PubMed Web of Science ®Google Scholar
• Kamal A, Ashraf M, Basha ST, et al. Design, synthesis and antiproliferative activity of new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors. Org Biomol Chem 2016;14:1382–94.
   PubMed Web of Science ®Google Scholar
• Clarke PR, Allan LA. Cell-cycle control in the face of damage-a matter of life or death. Trends Cell Biol 2009;19:89–98.
   PubMed Web of Science ®Google Scholar
• Liu Y-N, Wang J-J, Ji Y-T, et al. Design, synthesis, and biological evaluation of 1-methyl-1,4-dihydroindeno[1,2-c]pyrazole analogues as potential anticancer agents targeting tubulin colchicine binding sites. J Med Chem 2016;59:5341–55.
   PubMed Web of Science ®Google Scholar